SAB Biotherapeutics Inc.

AI Score

0

Unlock

0.08
0.00 (0.00%)
At close: Jan 15, 2025, 12:15 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -0.9 -1.37 -12.24 12.81 -468.57
PS Ratio 16.97 1.07 3.51 4.67 1.28K
PB Ratio 0.66 0.83 5.54 6.61 -1.91K
P/FCF Ratio -1.5 -3.57 -29.72 -94.51 -449.21
P/OCF Ratio -1.51 6.83 56.81 25.76 -478.89
OCF/S Ratio -11.22 0.16 0.06 0.18 -2.68
Debt / Equity Ratio 0.10 0.19 0.17 0.21 -3.31
Quick Ratio 5.45 1.47 1.96 3.11 2.01
Current Ratio 5.45 1.47 1.96 3.11 2.01
Asset Turnover 0.03 0.47 0.77 0.98 0.19
Interest Coverage -120.77 -95.89 -45.48 43.82 -20.24
Return on Equity (ROE) -0.74 -0.6 -0.45 0.52 4.08
Return on Assets (ROA) -0.5 -0.37 -0.22 0.36 -0.52
Return on Capital (ROIC) -0.52 -0.81 -0.24 0.45 -0.65
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin -67.28% 86.23% 97.28% 100.00% 100.00%
Net Profit Margin -1.88K% -78.4% -28.66% 36.42% -273.62%
Pretax Profit Margin -1.88K% -78.29% -28.16% 36.42% -261.09%
Operating Profit Margin -1.70K% -120.97% -22% 37.22% -252.01%
FCF Margin -1.13K% -30.06% -11.8% -4.94% -285.41%
EBITDA Margin -1.70K% -63.26% -24.96% 38.26% -239.25%